• ColonSentry is an advanced blood-based molecular diagnostic test that measures the expression of seven gene biomarkers for the early detection of colorectal cancer.
  • This 7‐gene, blood‐based biomarker panel can stratify subjects according to their current relative risk across a broad range in an average‐risk population.
  • ColonSentry requires no fasting, dietary restrictions, or special instructions
  • ColonSentry does not require patients to provide or handle any stool samples.
  • ColonSentry is simple & convenient and blood can be drawn at an exam before patients leave the office.

ColonSentry Patient Selection Criteria

The American Cancer Society recommends that people at average risk of colorectal cancer start regular screening at age 45. ³

Patients may be candidate for the ColonSentry Test if they are:

  • Age 45 or older and at average risk for Colorectal Cancer;
  • Are without symptoms such as bleeding, abdominal pain, or change in bowel habits;
  • Have not had a Colonoscopy or Stool-Based Screening Test.

³ American Cancer Society. Guideline for Colorectal Cancer Screening. Last revised May 30, 2018.

Download ColonSentry Physician Brochure

ColonSentry® Harnessing the Power of Gene Expression for Early Colorectal Cancer Detection